Gadoxetic acid (cas 135326-11-3)-enhanced MRI of transient hepatic enhancement differences: Another cause of hypointense observation on hepatobiliary phase

Add time:08/10/2019    Source:sciencedirect.com

PurposeTo retrospectively determine the frequency, natural history and factors associated with the presence of transient hepatic enhancement difference showing hypointensity on hepatobiliary phase images of gadoxetic acid-enhanced MRI.

We also recommend Trading Suppliers and Manufacturers of Gadoxetic acid (cas 135326-11-3). Pls Click Website Link as below: cas 135326-11-3 suppliers

Prev:Pyrrolidinamine, piperidinamine and tetrahydropyridazine derivatives from selenium promoted cyclization of alkenyl phenylhydrazones
Next:Relationship between transient severe motion of the liver in Gadoxetic acid (cas 135326-11-3) or iodinated contrast agent-enhanced imaging and arterial oxygen saturation and heart rate changes)